Efficacy of Magnesium and Alpha Lipoic Acid Supplementation in Reducing Premature Uterine Contractions
- Conditions
- Pregnancy
- Interventions
- Dietary Supplement: Magnesium plus alpha-lipoic acidDrug: Placebo
- Registration Number
- NCT02016495
- Lead Sponsor
- AGUNCO Obstetrics and Gynecology Centre
- Brief Summary
To evaluate whether a combined supplementation of magnesium and lipoic acid is able to significantly reduce the incidence of uterine contractions and related episodes of hospitalization in pregnant women.
- Detailed Description
Primary prevention of preterm labor is based on the early identification of risk factors and on appropriate treatments. Although several drugs are currently used, the identification of effective and safe agents able to improve both maternal and fetal health is still warranted.
In this study the efficacy a formulation based on magnesium and alpha-lipoic acid has been compared with placebo to evaluate the incidence of reduction of preterm delivery.
Three hundred pregnant women at 14-34 weeks of gestation were enrolled and randomly divided to receive a daily single tablet containing magnesium and alpha-lipoic acid supplement or placebo until delivery.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- Not specified
- 14-34 weeks of gestation
- Preexisting diabetes mellitus
- Systolic blood pressure >140mm Hg
- Cancer
- lupus
- hepatitis
- HIV/AIDS
- Diagnosed alcohol or chemical dependency
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Magnesium + Lipoic Acid Magnesium plus alpha-lipoic acid - Placebo Placebo -
- Primary Outcome Measures
Name Time Method Number of women with frequent and persistent episodes of preterm uterine contractions associated with pain From baseline (beginning of the treatment) until delivery Number of women with sporadic episodes of preterm uterine contraction From baseline (beginning of the treatment) until delivery Number of women needed for hospital admission for threatened preterm labour From baseline (beginning of the treatment) until delivery
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Clinica Villa delle Querce
🇮🇹Naples, Italy